Fennec Pharmaceuticals (FENC)

• Market cap: $255M
• 1 day: -4.97%
• 5 days: -3.12%
• 1 month: -2.99%
• 3 months: -14.84%
• 6 months: -13.86%
• Year to date: -2.86%
• 1 year: 14.77%
• 5 years: 1.36%
• 10 years: -37.83%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32